Ionis Pharmaceuticals, Inc. Other Nonoperating Expense
Ionis Pharmaceuticals, Inc. (IONS) reported Other Nonoperating Expense of $168.00 thousand for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-07.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2018-05-07
- Ionis Pharmaceuticals, Inc. other nonoperating expense for the quarter ending 2018-03-31 was $168.00K, a 88.32% decline year-over-year.
- Ionis Pharmaceuticals, Inc. other nonoperating expense for the quarter ending 2017-12-31 was $20.00K.
- Ionis Pharmaceuticals, Inc. other nonoperating expense for the quarter ending 2017-09-30 was $2.14M.
- Ionis Pharmaceuticals, Inc. other nonoperating expense for the quarter ending 2017-06-30 was $0.00.
- Ionis Pharmaceuticals, Inc. other nonoperating expense for fiscal 2017 was $3.55M.
- Ionis Pharmaceuticals, Inc. other nonoperating expense for fiscal 2016 was $0.00.
- Ionis Pharmaceuticals, Inc. other nonoperating expense for fiscal 2015 was $0.00.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month | Other Nonoperating Expense 9 month | Other Nonoperating Expense 12 month |
|---|---|---|---|---|
| 2018-03-31 | $168.00K 10-Q · filed 2018-05-07 | $188.00K derived: sum of 2 quarters · filed 2018-05-07 | $2.33M derived: sum of 3 quarters · filed 2018-05-07 | $2.33M derived: sum of 4 quarters · filed 2018-05-07 |
| 2017-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $2.16M derived: sum of 2 quarters · filed 2018-02-28 | $2.16M derived: sum of 3 quarters · filed 2018-02-28 | $3.55M 10-K · filed 2018-02-28 |
| 2017-09-30 | $2.14M 10-Q · filed 2017-11-07 | $2.14M derived: sum of 2 quarters · filed 2017-11-07 | $3.53M 10-Q · filed 2017-11-07 | $3.58M derived: sum of 4 quarters · filed 2018-05-07 |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 | $1.44M 10-Q · filed 2017-08-09 | $1.44M derived: sum of 3 quarters · filed 2018-05-07 | $1.44M derived: sum of 4 quarters · filed 2018-05-07 |
| 2017-03-31 | $1.44M 10-Q · filed 2018-05-07 | $1.44M derived: sum of 2 quarters · filed 2018-05-07 | $1.44M derived: sum of 3 quarters · filed 2018-05-07 | $1.44M derived: sum of 4 quarters · filed 2018-05-07 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $0.00 derived: sum of 2 quarters · filed 2018-02-28 | $0.00 derived: sum of 3 quarters · filed 2018-02-28 | $0.00 10-K · filed 2018-02-28 |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-09 | $0.00 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-09 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |